171 related articles for article (PubMed ID: 35210334)
1. Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis.
Lin Y; Parco C; Karathanos A; Krieger T; Schulze V; Chernyak N; Icks A; Kelm M; Brockmeyer M; Wolff G
BMJ Open; 2022 Feb; 12(2):e048893. PubMed ID: 35210334
[TBL] [Abstract][Full Text] [Related]
2. Clinical Efficacy and Safety of Bempedoic Acid in High Cardiovascular Risk Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Uddin N; Syed AA; Ismail SM; Ashraf MT; Khan MK; Sohail A
Curr Probl Cardiol; 2023 Dec; 48(12):102003. PubMed ID: 37516330
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and outcomes of Bempedoic acid versus placebo in patients with statin-intolerance: A pilot systematic review and meta-analysis of randomized controlled trials.
Goyal A; Changez MIK; Tariq MD; Mushtaq F; Shamim U; Sohail AH; Mahalwar G
Curr Probl Cardiol; 2024 Feb; 49(2):102236. PubMed ID: 38043880
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of bempedoic acid: a systematic review and meta-analysis of randomised controlled trials.
De Filippo O; D'Ascenzo F; Iannaccone M; Bertaina M; Leone A; Borzillo I; Ravetti E; Solano A; Pagliassotto I; Nebiolo M; Bruno F; Giacobbe F; Muscoli S; Monticone S; Brizzi MF; Biondi Zoccai G; De Ferrari GM
Cardiovasc Diabetol; 2023 Nov; 22(1):324. PubMed ID: 38017541
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial.
Goldberg AC; Leiter LA; Stroes ESG; Baum SJ; Hanselman JC; Bloedon LT; Lalwani ND; Patel PM; Zhao X; Duell PB
JAMA; 2019 Nov; 322(18):1780-1788. PubMed ID: 31714986
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis.
Cicero AFG; Fogacci F; Hernandez AV; Banach M;
PLoS Med; 2020 Jul; 17(7):e1003121. PubMed ID: 32673317
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials.
Venkatraman S; Das S; Eerike M; Cherian JJ; Bagepally BS
Eur J Clin Pharmacol; 2023 Nov; 79(11):1453-1463. PubMed ID: 37672112
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers for suspected or diagnosed acute myocardial infarction.
Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bempedoic acid for prevention of cardiovascular events and diabetes: a systematic review and meta-analysis.
Wang X; Zhang Y; Tan H; Wang P; Zha X; Chong W; Zhou L; Fang F
Cardiovasc Diabetol; 2020 Aug; 19(1):128. PubMed ID: 32787939
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
[TBL] [Abstract][Full Text] [Related]
11. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia.
Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL
JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Di Minno A; Lupoli R; Calcaterra I; Poggio P; Forte F; Spadarella G; Ambrosino P; Iannuzzo G; Di Minno MND
J Am Heart Assoc; 2020 Aug; 9(15):e016262. PubMed ID: 32689862
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Ray KK; Bays HE; Catapano AL; Lalwani ND; Bloedon LT; Sterling LR; Robinson PL; Ballantyne CM;
N Engl J Med; 2019 Mar; 380(11):1022-1032. PubMed ID: 30865796
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of bempedoic acid alone or combining with other lipid-lowering therapies in hypercholesterolemic patients: a meta-analysis of randomized controlled trials.
Zhao X; Ma X; Luo X; Shi Z; Deng Z; Jin Y; Xiao Z; Tan L; Liu P; Jiang S; Shu Y; Tang B; Qiu C
BMC Pharmacol Toxicol; 2020 Dec; 21(1):86. PubMed ID: 33276805
[TBL] [Abstract][Full Text] [Related]
15. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysis.
Mutschlechner D; Tscharre M; Huber K; Gremmel T
Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):583-591. PubMed ID: 37463824
[TBL] [Abstract][Full Text] [Related]
17. Effect of Bempedoic Acid on Serum Uric Acid and Related Outcomes: A Systematic Review and Meta-analysis of the available Phase 2 and Phase 3 Clinical Studies.
Cicero AFG; Pontremoli R; Fogacci F; Viazzi F; Borghi C
Drug Saf; 2020 Aug; 43(8):727-736. PubMed ID: 32358698
[TBL] [Abstract][Full Text] [Related]
18. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL
Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ETC-1002 in hypercholesterolaemic patients: a meta-analysis of randomised controlled trials.
Wang X; Luo S; Gan X; He C; Huang R
Kardiol Pol; 2019; 77(2):207-216. PubMed ID: 30740643
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
